In contrast, nigral neurons with tau aggregates displayed reductions of TH immunoreactivity in subjects with MMD (Fig. 6D–F), MMD-LB (Fig. 6G–I) and PD (Fig. 6J–L). This evidence concerns the gene MAPT and Parkinson disease.